Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression

  • Anja Lok*
  • , Roel J T Mocking
  • , Eric Ruhe
  • , Ieke Visser
  • , Maarten W J Koeter
  • , Johanna Assies
  • , Claudi L H Bockting
  • , Miranda Olff
  • , Aart H Schene
  • *Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

85 Citations (Scopus)
167 Downloads (Pure)

Abstract

BACKGROUND: Hypothalamic-pituitary-adrenal (HPA)-axis hyperactivity has been observed in (recurrent) major depressive disorder (MDD), although inconsistently and mainly cross-sectional. Longitudinal studies clarifying state-trait issues are lacking. We aimed to determine whether HPA-axis (hyper)activity in recurrent MDD is: (I) reflecting a persistent trait; (II) influenced by depressive state; (III) associated with stress or previous episodes; (IV) associated with recurrence; and (V) influenced by cognitive therapy.

METHODS: We included 187 remitted highly recurrent MDD-patients (mean number of previous episodes: 6.3), participating in a randomized-controlled-trial investigating the preventive effect of additional cognitive therapy on recurrence. In an add-on two-staged patient-control and prospective-cohort design, we first cross-sectionally compared patients' salivary morning and evening cortisol concentrations with 72 age- and sex-matched controls, and subsequently longitudinally followed-up the patients with repeated measures after three months and two years.

RESULTS: Patients had higher cortisol concentrations than controls (p<.001), which did not change by MDD-episodes during follow-up. HPA-axis activity had no relation with daily hassles or childhood life events. Cortisol concentrations were lower in patients with more previous episodes (p=.047), but not associated with recurrence(s) during follow-up. Finally, randomly assigned cognitive therapy at study-entry enhanced cortisol declines over the day throughout the two-year follow-up (p=.052).

CONCLUSIONS: Our results indicate that remitted recurrent MDD-patients have a persistent trait of increased cortisol concentrations, irrespective of stress. In combination with our finding that patients' cortisol concentrations do not change during new MDD-episodes (and thus not represent epiphenomenal or state-effects), our results support that hypercortisolemia fulfills the state-independence criterion for an endophenotype for recurrent depression.

Original languageEnglish
Pages (from-to)892-902
Number of pages11
JournalPsychoneuroendocrinology
Volume37
Issue number7
DOIs
Publication statusPublished - Jul-2012

Keywords

  • Depressive disorder
  • Major
  • Recurrence
  • Hypothalamo-hypophyseal system
  • Pituitary-adrenal system
  • Glucocorticoids
  • Saliva
  • Cohort studies
  • Case-control studies
  • Randomized controlled trial
  • Cognitive therapy
  • COMBINED DEXAMETHASONE/CRH TEST
  • WAKING SALIVARY CORTISOL
  • NEGATIVE LIFE EVENTS
  • HIGH FAMILIAL RISK
  • DEX-CRH TEST
  • MAJOR DEPRESSION
  • GLUCOCORTICOID-RECEPTORS
  • AFFECTIVE-DISORDERS
  • COGNITIVE THERAPY
  • OUTPATIENTS

Fingerprint

Dive into the research topics of 'Longitudinal hypothalamic-pituitary-adrenal axis trait and state effects in recurrent depression'. Together they form a unique fingerprint.

Cite this